RE:RE:Bladder Cancer Canada caseIt's important to note, also, that Keytruda and Adstiladrin are multiple-treatment solutions. TLT's trial was set up as limited to two instillations. Two!
In actual practice, nothing will prevent urologists from going to three, four, or even five instillations. Still less work than the competition, and CR's will surely skyrocket.
This solution is elegant, non-toxic, and surely, very attractive to patients seeking relief from this terrible affliction.
GLTA, especially the patients!